{"title":"Not Out of the Woods yet-a Case of Recurrent Euglycemic Diabetic Ketoacidosis Secondary to Empagliflozin and Pancreatitis","authors":"Marvin Wei Jie Chua","doi":"10.24966/dmd-201x/100038","DOIUrl":null,"url":null,"abstract":"Since their introduction, Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitors have demonstrated a multitude of exceptional clinical benefits.","PeriodicalId":15604,"journal":{"name":"Journal of Diabetes & Metabolic Disorders","volume":"28 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes & Metabolic Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24966/dmd-201x/100038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Since their introduction, Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitors have demonstrated a multitude of exceptional clinical benefits.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
